Dorman Products (DORM) Tops Q1 EPS by 54c; offers guidance

Dorman Products (NASDAQ: DORM) reported Q1 EPS of $2.02, $0.54 better than the analyst estimate of $1.48. Revenue for the quarter came in at $507.7 million versus the consensus estimate of $481.63 million.

GUIDANCE:

Dorman Products sees FY2025 EPS of $7.55-$7.85, versus the consensus of $7.69.

For earnings history and earnings-related data on Dorman Products (DORM) click here.

You May Also Be Interested In

• Robinhood Ventures Fund II opens at $22.50, IPO at $25
• SuperCom (SPCB) Tops Q3 EPS by 43c
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance